Lawrence M. Alleva - 24 Feb 2025 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Director
Signature
/s/ J. Mel Sorensen, Attorney-in-Fact for Lawrence M. Alleva
Issuer symbol
GRTX
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
4
Filing time
26 Feb 2025, 16:43:38 UTC
Previous filing
03 Jan 2025
Next filing
05 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +48,000 $0.000000 48,000 24 Feb 2025 Common Stock 48,000 $0.0410 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable on the earlier of February 24, 2026 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, subject to the Reporting Person continuing in service on the Board as a Non-Employee Director through such vesting date.